Norepinephrine is a major regulator of the release of growth hormone. Diethyldithiocarbamate, a dopamine-\g=b\-hydroxylase inhibitor, reduces norepinephrine synthesis and acutely inhibits growth hormone (GH) secretion. To investigate the long-term effects of dopamine-\g=b\-hydroxylase blockade on growth, we administered diethyldithiocarbamate (0, 40, 100 
Norepinephrine is a major regulator of the release of growth hormone. Diethyldithiocarbamate, a dopamine-\g=b\-hydroxylase inhibitor, reduces norepinephrine synthesis and acutely inhibits growth hormone (GH) (1) . After reversal of GHD or GH-resistant states, such as malnutrition, subjects resume normal growth velocity but the extent of accelerated "catch-up" growth varies.
Three rodent models of GHD have been developed: hypophysectomy (2) , neonatal administration of monosodium glutamate (MSG) (3) (4) (5) (6) and the inbred dwarf mouse (7, 8 Atlanta, 1990. Norepinephrine (NE) is an important regulator of GH secretion in the brain (9, 10) . Exogenous administration of NE or other a-adrenergic agonists evokes GH secretion (11, 12) . Blockade of NE synthesis using the dopamine-/?-hydroxylase (DBH) inhibitor diethyldithiocarbamate (DDTC) (13, 14) has been studied widely as a means of acutely suppressing GH secretion. As DDTC administra¬ tion results in a rapid decrease in spontaneous (11) and GHRH-induced GH secretion in rats (15) and in monkeys (16) , GH 
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Growth hormone was measured by RIA as described previously (18 (Fig. 2) . In three of these four studies, ( Fig. 2A-C) , growth of the DDTCtreated animals was accelerated following discontinua¬ tion of the drug ("catch-up" growth), so that at the end of the trials the animals' weights were no different from the controls (p>0.5). In the fourth study (Fig. 2D) However, food consumption was similar among all the groups studied. In humans, malnutrition is character¬ ized by GH elevation (22, 23) . This is not the case in rats (24) (25) (26) . Thus, GH levels could not be used in rats as an indicator of insufficient caloric intake. Administration of GH to malnourished patients and rats does not produce growth, because a GH resistance seems to occur (27 (24) . Similarly, Swanson 
